Resistance markers and genetic diversity in Acinetobacter baumannii strains recovered from nosocomial bloodstream infections

Int J Environ Res Public Health. 2014 Jan 28;11(2):1465-78. doi: 10.3390/ijerph110201465.

Abstract

In this study, phenotypic and genotypic methods were used to detect metallo-β-lactamases, cephalosporinases and oxacillinases and to assess genetic diversity among 64 multiresistant Acinetobacter baumannii strains recovered from blood cultures in five different hospitals in Brazil from December 2008 to June 2009. High rates of resistance to imipenem (93.75%) and polymyxin B (39.06%) were observed using the disk diffusion (DD) method and by determining the minimum inhibitory concentration (MIC). Using the disk approximation method, thirty-nine strains (60.9%) were phenotypically positive for class D enzymes, and 51 strains (79.6%) were positive for cephalosporinase (AmpC). Using the E-test, 60 strains (93.75%) were positive for metallo-β-lactamases (MβLs). All strains were positive for at least one of the 10 studied genes; 59 (92.1%) contained blaVIM-1, 79.6% contained blaAmpC, 93.7% contained blaOXA23 and 84.3% contained blaOXA51. Enterobacteria Repetitive Intergenic Consensus (ERIC)-PCR analysis revealed a predominance of certain clones that differed from each other. However, the same band pattern was observed in samples from the different hospitals studied, demonstrating correlation between the genotypic and phenotypic results. Thus, ERIC-PCR is an appropriate method for rapidly clustering genetically related isolates. These results suggest that defined clonal clusters are circulating within the studied hospitals. These results also show that the prevalence of MDR A. baumannii may vary among clones disseminated in specific hospitals, and they emphasize the importance of adhering to appropriate infection control measures.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acinetobacter baumannii / enzymology
  • Acinetobacter baumannii / genetics*
  • Bacteremia / genetics
  • Bacteremia / microbiology*
  • Cephalosporinase / metabolism
  • Cross Infection / genetics
  • Cross Infection / microbiology*
  • Drug Resistance, Bacterial / genetics*
  • Genetic Variation
  • Genotype
  • Genotyping Techniques
  • Humans
  • Microbial Sensitivity Tests
  • Phenotype
  • beta-Lactamases / genetics
  • beta-Lactamases / metabolism

Substances

  • Cephalosporinase
  • beta-Lactamases
  • oxacillinase